Skip to content
Bacteriophage - Tag Line Banner

Welcome to the 2nd Bacteriophage Therapy Summit 2020

The 2nd Bacteriophage Therapy Summit returns once again to bring together industry, leading academics, regulatory bodies and technology experts to accelerate the clinical development, regulation and approval of bacteriophage products.

As we enter the post-antibiotic era, the re-emergence of phage therapy acts as a potential viable replacement for antibiotics. However, the re-emergence does not come without challenges; large scale production, showing efficacy in the clinical setting and navigating a developing regulatory field are just a few limitations the field is currently facing.

This is your opportunity to join leaders developing the next generation of phage therapy products to discuss the latest case-studies and forge collaborations to unlock the full potential of bacteriophage therapeutics.

Book Today to Secure Your Place

Meet Our World-Class Speaker Faculty

Eric Pelfrene

Scientific Officer

EMA

Nancy Tawil

VP, Human Health Research

Phagelux

Scott Stibitz

Chief, Laboratory of Mucosal Pathogens & Cellular Immunology

FDA

Xavier Duportet

Co-Founder & CEO

Eligo Bioscience

Greg Merril

Co-Founder & CEO

Adaptive Phage Therapeutics

Lorenzo Corsini

Co-Founder & CEO

PhagoMed

Rebecca Reindel

Medical Officer

FDA

Sailaja Puttagunta

CMO

BiomX

2020 Partners to Date

BIA Separations
Loop Genomics
Proteon Pharmaceuticals